Cargando…

Treatment options for lower-risk myelodysplastic syndromes. Where are we now?

Myelodysplastic syndromes (MDS) are a spectrum of clonal stem-cell disorders characterized clinically by bone-marrow failure. Resultant cytopenias are responsible for significant mortality and decreased quality of life in patients with MDS. In patients with low-risk MDS (LR-MDS), anemia is the most...

Descripción completa

Detalles Bibliográficos
Autores principales:	Volpe, Virginia O., Komrokji, Rami S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812395/ https://www.ncbi.nlm.nih.gov/pubmed/33505645 http://dx.doi.org/10.1177/2040620720986641

Ejemplares similares

Lower‐risk myelodysplastic syndromes: Current treatment options for anemia
por: Meunier, Mathieu, et al.
Publicado: (2022)

The evolution of lower gastrointestinal endoscopy: where are we now?
por: Sivananthan, Arun, et al.
Publicado: (2020)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes
por: Abou Zahr, Abdallah, et al.
Publicado: (2014)

Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes
por: Komrokji, R. S., et al.
Publicado: (2016)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Treatment of uveal melanoma: where are we now?
por: Yang, Jessica, et al.
Publicado: (2018)

Hepatitis C treatment: where are we now?
por: Burstow, Nicholas J, et al.
Publicado: (2017)

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
por: Komrokji, Rami S., et al.
Publicado: (2023)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Where are we now?
Publicado: (1977)

Osteopontin and Transplantation: Where Are We Now?
por: Kaleta, Beata
Publicado: (2021)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Microbiota and Obesity: Where Are We Now?
por: Ballini, Andrea, et al.
Publicado: (2020)

Genetics of migraine: where are we now?
por: Grangeon, Lou, et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update
por: Jain, Akriti G., et al.
Publicado: (2022)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
por: Omarini, Claudia, et al.
Publicado: (2018)

A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?
por: Griffin, Morag, et al.
Publicado: (2020)

Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?
por: Bae, Esther Y., et al.
Publicado: (2021)

Chemoquiescence for Ideal Cancer Treatment and Prevention: Where Are We Now?
por: Kangwan, Napapan, et al.
Publicado: (2014)

Treatment of Neuroendocrine Neoplasms with Radiolabeled Peptides—Where Are We Now
por: Naik, Mitesh, et al.
Publicado: (2022)

Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?
por: Chan, Joyce W. Y., et al.
Publicado: (2023)

Cardiovascular Tissue Engineering: Where We Come From and Where Are We Now?
por: Smit, Francis E., et al.
Publicado: (2015)

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
por: AHMED, MOHAMED H
Publicado: (2018)

Future Perspectives in Pediatric Dentistry: Where are We Now and where are We Heading?
por: Rodrigues, Jonas A, et al.
Publicado: (2022)

Retinal Organoid Technology: Where Are We Now?
por: Zhang, Zuming, et al.
Publicado: (2021)

Pioglitazone in Clinical Practice: Where Are We Now?
por: Govindan, Joytish, et al.
Publicado: (2012)

Pediatric SJS-TEN: Where are we now?
por: Ramien, Michele, et al.
Publicado: (2020)

Exercise stress echocardiography: Where are we now?
por: Cotrim, Carlos Alberto, et al.
Publicado: (2022)

Metformin and Breast Cancer: Where Are We Now?
por: Cejuela, Mónica, et al.
Publicado: (2022)

Immunotherapy and Hepatocellular Cancer: Where Are We Now?
por: Valery, Marine, et al.
Publicado: (2022)

Vaccines against Tuberculosis: Where Are We Now?
por: Srivastava, Shruti, et al.
Publicado: (2023)

Mechanism of diabetic neuropathy: Where are we now and where to go?
por: Yagihashi, Soroku, et al.
Publicado: (2011)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2kmmo8lckk4kslahvr6nv10e9n